Live metrics across your nephrology billing cycle
No other specialty in medicine has a billing structure as unique as nephrology. ESRD monthly capitation bundles, stage-based CKD E/M coding, four distinct dialysis modalities with separate CPT families, transitional care management codes, kidney transplant follow-up billing, and an increasingly complex prior authorization burden — it all operates under rules that generalist billing teams simply don't know. ParaMed's nephrology-certified billing team understands every dimension of the nephrology billing engine — and keeps every component running at peak performance.
Real-time nephrology billing — from dialysis round-sheet capture to ESRD bundle submission and payment confirmation.
Nephrology is unique in medicine because ESRD patients on dialysis are billed through Medicare's monthly capitation bundle system — a fundamentally different financial model from the fee-for-service billing used for all other nephrology services. ParaMed manages both universes with equal precision.
Medicare pays nephrologists a monthly capitated fee for managing ESRD patients — covering all dialysis-related services performed during that month, regardless of the number of visits. The specific monthly code depends on the patient's age, dialysis setting, and the number of face-to-face physician visits documented in the month.
90960 (≥4 visits/month), 90961 (2–3 visits), 90962 (1 visit). The number of face-to-face physician evaluations documented in the month determines the specific code — and the reimbursement.
90960 / 90961 / 90962Separate ESRD monthly code families for pediatric patients: 90951–90953 (age <2), 90954–90956 (age 2–11), 90957–90959 (age 12–19). Age documentation must match the ESRD CPT family billed.
90951–90959Home dialysis patients (both PD and home HD) have their own monthly management code family. Documentation of monthly review method determines the code.
90963 / 90964 / 90965The ESRD bundle covers dialysis-related E/M — but explicitly does NOT include: hospitalizations, unrelated office visits, transplant care, and many procedures. Knowing what escapes the bundle is critical to capturing full revenue.
Separate billing applies — see rulesUnder the expanded ESRD bundle, ESA drugs are included in the facility composite rate — not separately billable by the nephrologist. Understanding what is and isn't separately billable prevents duplicate billing audit triggers.
Facility-billed — J0881/J0882/J0885All nephrology services for CKD patients not yet on dialysis, consultations, hospital-based nephrology, transplant follow-up, and procedure-based services are billed fee-for-service — each service generating its own claim with its own code, modifier, and medical necessity documentation requirements.
Office visits for CKD management require ICD-10 codes that specify both the CKD stage (N18.1–N18.5) and, where applicable, the underlying cause. Unspecified CKD (N18.9) is a major audit red flag.
99213 / 99214 / 99215 + N18.xInitial hospital nephrology consultations (99252–99255), hospital admissions (99221–99223), and subsequent hospital visits (99231–99233) with AKI, electrolyte disorders, and acute glomerulonephritis billing.
99252–99255 / 99221–99223 / 99231–99233TCM codes (99495/99496) for patients discharged from hospital or SNF — highly reimbursed and frequently missed in nephrology. Kidney disease patients have high readmission rates, making TCM highly applicable.
99495 / 99496 — frequently missedPost-transplant nephrology management — the nephrologist's separate medical management of rejection prophylaxis, immunosuppression monitoring, and unrelated conditions is separately billable with appropriate documentation.
99213–99215 + Z94.0 post-transplantPercutaneous kidney biopsy (50200) — includes imaging guidance (US guidance 76942 separately billable). The pathology interpretation (88305) is separately billable when the nephrologist reads their own biopsy — a frequently missed revenue item.
50200 / 76942 / 88305 — triple billingThese are the systematic revenue failures found in virtually every nephrology practice operating with generalist billing. Each one is measurable, preventable, and compounding monthly. The total annual impact for a 3–5 nephrologist group typically exceeds $200,000 in recoverable revenue.
The ESRD monthly bundle code is determined by the number of face-to-face physician evaluations documented in that calendar month. 90960 (≥4 visits) reimburses ~$266; 90961 (2–3 visits) ~$216; 90962 (1 visit) ~$166. For a nephrologist managing 100 ESRD patients, a single code-tier error on every patient is $5,000+ per month in lost revenue.
The ESRD monthly bundle covers dialysis-related management — but an enormous category of nephrology services for ESRD patients is explicitly NOT included and is separately billable. Acute conditions unrelated to ESRD, hospitalizations, procedures, and transplant evaluations are all separately billable. When billing teams treat the monthly bundle as covering everything for the patient in that month, all non-ESRD services are effectively written off.
TCM codes (99495/99496) are among the highest-reimbursed outpatient E/M codes — $175–$234 — and apply every time a nephrology patient is discharged from hospital, skilled nursing facility, or rehab. CKD and ESRD patients have among the highest re-hospitalization rates in medicine, meaning TCM opportunities are frequent. Without a systematic TCM tracking process, virtually all TCM revenue goes uncaptured.
Medicare and commercial payers increasingly require specific CKD stage coding (N18.1 through N18.6) rather than the unspecified N18.9 code that many generalist billing teams default to. Additionally, the etiology of CKD must be coded when documented — diabetic nephropathy, hypertensive CKD, and glomerular disease each have specific combination codes that affect medical necessity determination and risk adjustment.
When a nephrologist performs a percutaneous kidney biopsy, three billing components exist: (1) biopsy procedure code 50200, (2) ultrasound guidance 76942, and (3) pathological interpretation code 88305 when the nephrologist personally reads the biopsy specimen. Most billing teams capture only 50200 — missing the imaging guidance and the pathology interpretation component.
The month a patient begins dialysis (ESRD initiation) and the months around significant transitions — switching dialysis modality, transferring to a different facility, receiving a kidney transplant, or dying — all have specific billing rules that differ from standard monthly management. Without a tracking system for patient status transitions, these high-risk billing periods are frequently miscoded or simply missed.
Each dialysis modality has a distinct billing structure, code family, and compliance requirements. Select any modality to see exactly how ParaMed manages billing across the full spectrum of nephrology dialysis services.
In-center hemodialysis is the most common dialysis modality and the foundation of nephrology billing. The nephrologist managing ESRD patients receiving in-center HD bills monthly management codes based on visit count (90960/90961/90962 for adults). The critical distinction is between routine monthly management (bundled) and acute evaluation services performed during a dialysis session in response to a specific clinical event or finding.
Adult patient, physician performs ≥4 documented face-to-face evaluations in the calendar month. Each evaluation must be documented in the patient chart — round-sheet documentation alone is insufficient.
Most commonly billed ESRD code for practices without visit-count tracking. Should be 90960 for patients with ≥4 documented visits — but defaults to 90961 when billing teams don't reconcile visit counts against monthly bundles.
Separately billable evaluation during a specific dialysis session for a distinct clinical problem or acute event — not routine monthly management. Requires documentation of the specific clinical issue evaluated during the session.
More comprehensive evaluation during a dialysis session — appropriate when the physician performs a complete evaluation including access assessment, review of fluid status, labs, and clinical decision making beyond routine management.
The visit count for ESRD monthly code selection must be reconciled against actual documented evaluations for the month. Round-sheet checkmarks are not sufficient — each face-to-face evaluation must be separately documented in the patient record.
ESRD monthly management codes cover services in a specific calendar month — not a rolling 30-day window. Partial months (ESRD initiation, patient death, transplant) have specific pro-rating rules that differ from full-month billing.
Only one physician can bill the monthly ESRD bundle for a given patient in a given month. In group practice settings, the managing physician who performed the majority of face-to-face services bills the bundle.
Hospital admissions, ICU care, and emergency department services are not included in the ESRD monthly bundle. Hospital billing (99221–99223, 99231–99233) is separate from the monthly outpatient ESRD bundle claim.
Peritoneal dialysis (both CAPD and CCPD) is billed through the home dialysis monthly management code family. The nephrologist managing a PD patient doesn't visit the dialysis center — instead, monthly management is documented through a combination of in-person clinic visits, telephone contacts, telehealth encounters, and review of the patient's home PD logs and laboratory data.
Adult patient managed on home PD or home HD with ≥3 contacts per month (combination of in-person, telehealth, and telephone contacts). At least one contact must be a face-to-face or telehealth encounter.
Adult home dialysis with 2 documented contacts in the month. Every eligible patient for 90963 should be coded at that level when documentation supports it.
Unscheduled management services for home dialysis patients — separately billable from the monthly management code when an acute clinical issue requires separate evaluation outside the routine monthly management pattern.
Used for ESRD management on a per-day basis when monthly management is not appropriate — transitions, short-term responsibility, or temporary coverage periods.
For home dialysis monthly management, every contact counted toward the monthly tier must be documented — in-person visit note, telehealth encounter note, or telephone contact documented in the chart with date, duration, and clinical content.
Review of the patient's home PD logs, fluid balance records, and blood pressure diary may qualify as a clinical contact when documented — providing a clinical summary of what was reviewed and any decisions made.
Medicare covers telehealth visits as face-to-face contacts for home dialysis management. Telehealth contacts require specific documentation of the technology platform and patient consent.
Peritoneal dialysis training (90989 complete, 90993 per session) is separately billable for PD patient training — distinct from the monthly management codes and applying during the initial training period.
Home hemodialysis is the fastest-growing dialysis modality in the US. HHD uses the same monthly management code family as peritoneal dialysis (90963–90966) — but HHD patients require more frequent monitoring due to the higher technical demands of home HD, creating both a higher contact frequency and a correspondingly higher monthly management tier for most patients.
Most HHD patients qualify for the ≥3 contact tier due to the frequency of clinical monitoring required. Remote HD machine data review, blood pressure log review, and regular telephone follow-up each constitute documented contacts when charted correctly.
Initial home dialysis training — complete training program for the patient and caregiver. Separately billable from the ongoing monthly management codes. Comprehensive training period documentation is required.
Individual training session code when training is provided in session increments rather than as a complete program. Used when additional training is required after initial program completion.
Collection and interpretation of physiological data from home HD remote monitoring — separately billable when the nephrologist spends ≥30 minutes in a 30-day period reviewing and interpreting remote monitoring data.
When remote HD machine data is reviewed as part of monthly management, the review should be documented as a clinical contact — including what data was reviewed, clinical interpretation, and any management changes made.
Home dialysis training codes (90989/90993) are never billed in the same month as the ongoing monthly management codes — they represent the training period, which precedes ongoing management.
When a care partner or family member performs the HHD treatments, their training is a separate billable component. Training documentation should identify both the patient and the caregiver being trained.
Practices participating in the ESRD Treatment Choices (ETC) model receive payment adjustments based on home dialysis rates. Billing accuracy for home dialysis codes directly affects ETC performance metrics.
CRRT and SLED are acute inpatient dialysis modalities used for AKI management in ICU and critical care settings. Unlike ESRD monthly management, CRRT/SLED billing is per-session or per-day — with the nephrologist billing for evaluation and management of the dialysis session in the context of the overall inpatient care. The critical billing distinction is between the dialysis procedure itself (facility-billed) and the nephrologist's physician evaluation component.
Nephrologist's evaluation during a specific dialysis/CRRT session — covers the physician's clinical assessment, prescription review, and management decisions for that session. The facility bills for the CRRT equipment and nursing separately.
More comprehensive evaluation with access assessment, adequacy review, clinical problem-solving, and management decisions. CRRT patients with AKI, sepsis, and multi-organ dysfunction often qualify for 90947 over 90945.
Daily subsequent hospital visit for AKI/CRRT management — the primary billing vehicle for nephrology inpatient care alongside the dialysis session evaluation code. CRRT patients typically support 99232 or 99233 based on their clinical complexity.
When the nephrologist personally provides critical care services (≥30 minutes of direct critical care time documented) for a critically ill AKI patient, critical care codes may replace the standard subsequent hospital visit — significantly higher reimbursement.
On days when both a dialysis evaluation (90945/90947) and a separate subsequent hospital visit occur on the same day by the same physician, only one can be billed — the dialysis code includes the E/M component for the dialysis encounter.
Critical care billing requires documentation of the time spent in direct critical care — stating the start time, end time, or total minutes. Critical care time cannot be inferred from the note — it must be explicitly stated.
AKI coding requires specificity: N17.0 (AKI with tubular necrosis), N17.1 (AKI with cortical necrosis), N17.2 (AKI with medullary necrosis), N17.9 (unspecified AKI). Specific AKI coding improves medical necessity documentation and HCC capture.
If the nephrologist places the dialysis access catheter, the procedure is separately billable from the CRRT management codes. Temporary HD catheter (36620) or tunneled catheter (36558) requires documentation of technique and confirmation of placement.
CKD billing requires a different strategy at each stage of kidney disease progression — from the initial nephrology consultation in CKD Stage 3 through the monthly bundle management of ESRD. Each stage transition creates new billing opportunities that must be recognized and captured.
Stage 1 CKD is typically managed in primary care. Nephrology consultation (99252–99255) is appropriate when proteinuria, hematuria, or GFR decline rate indicates nephrology evaluation. The nephrology consult note must document the clinical indication for nephrology involvement to support the consult level.
Stage 2 CKD requires documentation and coding of the underlying etiology — diabetic nephropathy (E11.65), hypertensive CKD (I12.9), or glomerular disease. ICD-10 combination codes capture both the etiology and the CKD in a single code — critical for risk adjustment (HCC capture) and medical necessity documentation.
HCC risk: missing etiology combination codes reduces RAF score — financial impact beyond billing denial risk.
Stage 3 CKD introduces anemia management, mineral and bone disorder management, and CKD-MBD workup. ICD-10 now distinguishes 3a (N18.3a, GFR 45–59) from 3b (N18.3b, GFR 30–44) — a critical specificity distinction that affects risk adjustment significantly. Most billing teams miss the 3a/3b distinction.
N18.3a vs. N18.3b distinction added in ICD-10-CM 2023 — most billing teams still use undifferentiated N18.3.
Stage 4 CKD is the critical preparation phase — when dialysis access planning, transplant evaluation, and ESRD education begin. Transplant evaluation referrals, AV fistula creation referral coordination, and ESRD education (patient education CPT 98960–98962) are all separately billable. The density of nephrology billable services increases significantly at Stage 4.
CKD Stage 5 (non-dialysis) is the most billing-sensitive transition zone in nephrology. The month dialysis begins is the ESRD enrollment month — and the billing transition from fee-for-service to monthly bundle must happen precisely. Billing the monthly ESRD bundle before dialysis initiation — or continuing to bill fee-for-service E/M for dialysis-related services after ESRD enrollment — creates compliance exposure in both directions.
Transition month billing error: starting ESRD bundle before dialysis first date creates billing fraud exposure.
ESRD monthly bundle billing (90960–90966 based on modality and visit frequency) is the primary billing vehicle — but the full scope includes managing the bundle, identifying and separately billing all non-bundle services, tracking patient transitions (modality changes, hospitalizations, transplant events), and managing the ESRD billing through transplant month and post-transplant follow-up. N18.6 is the primary diagnosis on all ESRD monthly bundle claims.
These are the nephrology revenue categories that generalist billing teams most frequently lose — shown as percentage of practices affected and typical annual revenue impact per nephrology group.
Revenue categories that flow through generalist billing uncaptured
Every nephrology revenue category tracked, verified, and billed
Six core service components — each built specifically for the nephrology billing environment, with the specialty knowledge to capture every revenue category your practice generates across the full CKD-to-ESRD spectrum.
Visit count reconciliation, pediatric vs. adult code family verification, monthly billing calendar management, and patient transition tracking — ensuring every ESRD patient is billed at the correct monthly code tier, every month, with zero transition-month errors.
A dedicated TCM tracking workflow that captures every nephrology patient discharge — generating a 2-day contact task and 7/14-day face-to-face visit task for every applicable discharge. For nephrology groups with significant inpatient volume, TCM billing alone generates $40K–$120K in additional annual revenue.
Stage-specific ICD-10 coding (N18.1–N18.6, including the 2023 N18.3a/3b distinction), etiology combination code application, and Hierarchical Condition Category (HCC) capture for value-based care programs. For practices in Medicare Advantage or ACO programs, accurate CKD stage and etiology coding directly affects the practice's revenue through RAF score impact.
Complete procedure billing for kidney biopsy (50200 + US guidance 76942 + pathology interpretation 88305 when applicable), dialysis access procedures, and hospital procedure billing. The triple-component biopsy billing is one of the most consistently missed revenue opportunities in nephrology — our procedure billing team captures all three components on every qualifying biopsy.
Nephrology-specific denial arguments built around the ESRD billing rules, CKD medical necessity requirements, and TCM documentation standards. Our denial team maintains a nephrology-specific appeal library covering the most common denial types — ESRD visit count disputes, non-bundle service inclusion denials, TCM documentation denials, and CKD medical necessity challenges.
Medicare is the dominant payer in nephrology — ESRD patients are Medicare-eligible regardless of age. But the full payer landscape includes Medicare Advantage, Medicaid, and commercial plans, each with specific nephrology coverage and prior authorization rules.
The dominant nephrology payer — ESRD patients receive Medicare coverage regardless of age at ESRD onset. The ESRD monthly bundle rates are CMS-set. NCD and MAC LCD policies govern separately billable ESRD services, CKD medical necessity, and procedure coverage.
MA plans follow Medicare ESRD billing rules but may have independent PA requirements for high-cost services. PA for ESA therapy, dialysis access procedures, and transplant evaluations is common in MA plans with restrictive utilization management policies.
Commercial payers cover CKD management for patients not yet on dialysis. Coverage for nephrology services varies significantly — prior authorization for nephrology consultations, biologics for CKD-related anemia, and procedures is common and payer-specific.
Medicaid covers nephrology services for low-income CKD patients not yet on Medicare ESRD. State Medicaid programs vary significantly in nephrology coverage, PA requirements, and reimbursement rates.
Nephrologists in ACO or other value-based care arrangements have additional financial incentives tied to CKD coding accuracy, ESRD prevention, and home dialysis utilization. Correct CKD staging and HCC capture directly affect shared savings calculations.
CMS ESRD-specific demonstration and payment models — including the ESRD Treatment Choices (ETC) model — create additional payment adjustment opportunities tied to home dialysis rates and performance on quality metrics.
These are the performance benchmarks we establish at onboarding and track every month against your pre-engagement baseline — because accountability is the only measure of a billing partner that actually matters.
Every nephrology onboarding starts with a free specialty audit identifying your ESRD bundle errors, TCM gaps, and CKD coding deficiencies. We build your complete billing protocol and submit first claims within 10 business days — with a performance report at Day 30 showing exact before/after comparison.
We audit a representative sample of your recent claims — coding your ESRD monthly bundles against documented visit counts, identifying TCM billing gaps from recent discharges, reviewing CKD stage and etiology code specificity, and checking biopsy codes for the three-component capture. You receive a written audit report with quantified revenue impact per category within 48 hours.
We document your complete ESRD patient roster by modality (in-center HD, home HD, PD), establish visit count tracking for monthly bundle submission, set up the TCM tracking workflow for discharge alerts, build your CKD coding protocol including etiology combination codes and the 2023 N18.3a/3b distinction, and configure payer-specific rules for your exact payer mix.
We integrate with your EHR and practice management system — configuring our billing workflow to receive round-sheet data, encounter documentation, and discharge notifications efficiently. We train your clinical staff on the documentation elements that directly affect billing — creating the documentation quality that supports maximum revenue.
First nephrology claims are submitted within 24 hours of receiving completed documentation. Every claim passes our nephrology-specific pre-submission review — ESRD visit count reconciliation, CKD code specificity verification, NCCI edit compliance check, and modifier accuracy review.
Your first monthly performance dashboard is delivered at Day 30 — including ESRD bundle accuracy vs. baseline, TCM capture rate and revenue, CKD coding accuracy metrics, denial rate by claim type, and a revenue comparison vs. the pre-engagement audit findings. This report is the accountability document that proves the value of specialty billing — in your numbers, for your practice.
"We had been billing ESRD monthly bundles for years and never once had our billing team reconcile the visit count against the documentation before submission. They always billed 90961 — the 2–3 visit code — for every patient, regardless of how many times we actually saw them. ParaMed audited 90 days of our ESRD billing and found that 68% of our patients qualified for the higher 90960 code based on documented visit counts. After correcting this single error across our 200-patient ESRD census, our monthly ESRD revenue increased by $9,800 per month. That's $117,600 per year from one billing correction that took ParaMed less than a week to identify and fix."
"We had never billed a single TCM code in the history of our nephrology group. Our previous billing team didn't even know what TCM was. ParaMed set up a discharge tracking process and we started capturing TCM billing for our high-acuity CKD and ESRD patients. In the first full year, we generated $94,000 in TCM revenue that was previously completely uncaptured. It was essentially found money."
"Our practice does approximately 40 kidney biopsies per year. ParaMed's audit showed that we had been submitting only the biopsy procedure code (50200) on every one of them — never billing the ultrasound guidance or the pathology interpretation component. After correcting to the triple-code billing model, we recovered $7,800 in annual biopsy revenue that was previously going unbilled."
We review your ESRD bundle coding, TCM billing history, CKD stage specificity, and biopsy code completeness — and deliver a written revenue impact report within 48 hours. No obligation, no commitment, just a clear picture of what your practice is currently leaving behind.
We code a sample of your recent ESRD monthly claims against the documented visit counts — identifying every patient where the billed tier is lower than the documentation supports and calculating the monthly and annual revenue recovery opportunity.
We review your discharge history for the last 90 days and identify every TCM-eligible event that was not billed — with a calculated first-year TCM revenue projection based on your patient population's discharge frequency.
We analyze your CKD ICD-10 coding for stage specificity (including N18.3a/3b), etiology combination code usage, and HCC capture completeness — with an estimated RAF score impact for practices in risk-adjusted payment models.
Every finding is documented with specific dollar estimates per revenue category — giving you a concrete ROI calculation before any engagement decision is required.
"The audit was done in under 48 hours. The report showed $11,400 per month in recoverable revenue — $9,800 from ESRD bundle tiers, $1,600 from missed non-bundle services. We signed the same day the report arrived. The first month's billing was higher than any month we'd ever had under our previous team."
No cost. No commitment. A written report showing exactly what your nephrology practice is leaving behind — across ESRD bundles, TCM, CKD coding, and procedures.
Audit covers: ESRD bundle tiers, TCM gaps, CKD specificity, biopsy codes, transition month billing, payer mix analysis
From ESRD monthly bundle tier precision to the TCM revenue your practice has never captured, from CKD stage ICD-10 specificity to the triple-component kidney biopsy billing that your generalist team doesn't know exists — ParaMed's nephrology-certified billing specialists manage every dimension of your nephrology revenue cycle with the specialty knowledge it demands.
Trusted by Practices Across US — Feedback from providers who rely on ParaMed for smarter Medical Billing.
